期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Objective: This study aimed to build and validate a radiomics-integrated model with whole-brain magnetic resonance imaging (MRI) to predict the progre......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background and purpose: Although grading scales for angiography outcomes following cerebral aneurysm treatment with flow diversion have been published......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background and aims: The role of statins in unruptured intracranial aneurysm (UIA) growth and rupture remains ambiguous. This study sought to determin......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background: Intraplaque neovascularisation (IPN) increases the vulnerability of plaques, which makes them more likely to rupture and increases the ris......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background: We aimed to evaluate the diagnostic yield of seven-tesla (7T) magnetic resonance imaging (MRI) with post-processing of three-dimensional (......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background: The high comorbidity of migraine and depression is suggestive of shared risk factors or common mechanisms between the two diseases. In ind......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neur......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background: To date, few data have been reported on clinical outcomes following interventions in elderly populations with acute basilar artery occlusi......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background and Aims: Although noninferior to stent retriever (SR) as first-line approach for endovascular treatment (EVT) of acute large vessel occlus......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Aim: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a subgroup of treatable autoimmune encephalitis, characterized by rapid developme......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background: Blood pressure (BP), recanalization status, and collateral circulation are important factors for cerebral autoregulation after stroke. We ......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Immune-mediated necrotizing myopathy (IMNM) is a group of immune-related myopathies characterized by progressive proximal muscle weakness, extremely h......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021; 14 ()
Background: Intravenous immunoglobulin (IVIG) has been commonly used to treat myasthenia gravis exacerbation, but is still ineffective in nearly 30% o......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020; 13 ()
Background: Diagnostic criteria for multiple sclerosis have evolved over time, with the most recent being the 2017 McDonald criteria. Evidence is lack......
期刊： THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020; 13 ()
Background: Short segment myelitis (SSM, < 3 vertebral segments) is an under-recognized initial manifestation of neuromyelitis optica spectrum diso......
